IFPMA 2015 interview series ‘Fake medicines: what are they? / Les faux médicaments: de quoi s’agit-ils?’
Share
Ms Cyntia Genolet, IFPMA’s Policy Analyst, Regulatory & Health Policy and leads the organisation’s anti-counterfeiting portfolio, together with Marc Gentilini, General Delegate of ‘Fondation Chirac’ give their take on what fake medicines are and how to curb their threat.
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.Media Contact
Elliot Dunster e.dunster@ifpma.org